Musiał-Kopiejka, M.; Polanowska, K.; Dobrowolski, D.; Krysik, K.; Wylęgała, E.; Grabarek, B.O.; Lyssek-Boroń, A.
The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. Int. J. Environ. Res. Public Health 2022, 19, 2303.
https://doi.org/10.3390/ijerph19042303
AMA Style
Musiał-Kopiejka M, Polanowska K, Dobrowolski D, Krysik K, Wylęgała E, Grabarek BO, Lyssek-Boroń A.
The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. International Journal of Environmental Research and Public Health. 2022; 19(4):2303.
https://doi.org/10.3390/ijerph19042303
Chicago/Turabian Style
Musiał-Kopiejka, Magdalena, Katarzyna Polanowska, Dariusz Dobrowolski, Katarzyna Krysik, Edward Wylęgała, Beniamin Oskar Grabarek, and Anita Lyssek-Boroń.
2022. "The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration" International Journal of Environmental Research and Public Health 19, no. 4: 2303.
https://doi.org/10.3390/ijerph19042303
APA Style
Musiał-Kopiejka, M., Polanowska, K., Dobrowolski, D., Krysik, K., Wylęgała, E., Grabarek, B. O., & Lyssek-Boroń, A.
(2022). The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. International Journal of Environmental Research and Public Health, 19(4), 2303.
https://doi.org/10.3390/ijerph19042303